Conditions: ADHD Specifically With Executive Function Impairment
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 161
Healthy volunteers: no

Brief summary:
The primary objective of the study is to evaluate the efficacy of SPD489 compared to placebo on executive function (self-regulation) behaviors in adults with ADHD who report clinically significant impairment of executive function behavior in their everyday environment, as measured by the self-report Behavior Rating Inventory of Executive Function - Adult Version (BRIEF-A) Global Executive Composite (GEC) T-score.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: SPD489 intervention 2: Placebo
Intervention descriptions: intervention 1: 1 capsule per day (30, 50 or 70 mg), daily throughout the double-blind treatment period (10 weeks) intervention 2: 1 capsule per day, daily throughout the double-blind treatment period (10 weeks)

Protocol document: